LTRN · Lantern Pharma Inc.
$2.65
+0.02 (+0.76%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“there is substantial doubt about the Company's ability to continue as a going concern in the absence of obtaining substantial additional funding.”View the 10-Q filed Aug 14, 2026
Market Cap
$33.88M
Shares
12.78M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding LTRN
14 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 250,635 | $343,370 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 47,619 | $170,952 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 81,444 | $111,578 | 0.00% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 15,273 | $54,830 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 11,259 | $40,420 | 0.00% | Long | 2026-05-31 | |
| Horizon Kinetics Medical ETF | — | 26,373 | $36,131 | 0.20% | Long | 2026-03-31 | |
| iShares Micro-Cap ETF | — | 21,373 | $29,281 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 6,838 | $24,548 | 0.00% | Long | 2026-05-31 | |
| U.S. Social Core Equity 2 Portfolio | — | 9,704 | $19,893 | 0.00% | Long | 2026-04-30 | |
| U.S. SMALL CAP PORTFOLIO | — | 8,535 | $17,497 | 0.00% | Long | 2026-04-30 | |
| Dimensional US Sustainability Core 1 ETF | — | 1,924 | $3,944 | 0.00% | Long | 2026-04-30 | |
| 1290 VT Micro Cap Portfolio | — | 1,685 | $2,308 | 0.00% | Long | 2026-03-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 1,042 | $2,136 | 0.00% | Long | 2026-04-30 | |
| Dimensional US Core Equity 1 ETF | — | 4 | $8 | 0.00% | Long | 2026-04-30 |
Showing 1–14 of 14 positions
Key facts
CIK
1763950
CUSIP
51654W101
13F (30d)
39 filings
38 filers
Visit website
Investor relations